Victory for drugmakers GSK and Boehringer in $640 million Zantac cancer lawsuit ...Middle East

GSK said the outcome is “consistent with the scientific consensus that there is no consistent or reliable evidence” of increased cancer risks from Zantac.

Hence then, the article about victory for drugmakers gsk and boehringer in 640 million zantac cancer lawsuit was published today ( Friday 24/05/2024 - 12:29 PM ) and is available on Fortune ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Victory for drugmakers GSK and Boehringer in $640 million Zantac cancer lawsuit )

Also on site :

• Is Europe heading to an energy crisis?
• Dylan O’Brien & Hudson Williams Set For Sofia Banzhaf Thriller ‘Apparatus’
• LIVE: Spain vs Serbia – World Cup 2026 friendly